Charles Rowland's involvement with Viking Therapeutics has seen him hold a considerable amount of stock. In recent years, his trading activity reflects a strong belief in the company's future. Notably, in the last months alone, he executed transactions ranging from...

Charles Rowland's involvement with Viking Therapeutics has seen him hold a considerable amount of stock. In recent years, his trading activity reflects a strong belief in the company's future. Notably, in the last months alone, he executed transactions ranging from $700K to over $3 million. This includes timely sales and purchases that may align with important announcements or milestones for Viking. As of the latest reports, his stock holdings fluctuated, but they consistently represented a significant portion of his wealth, showing his confidence in the company. Rowland's trading patterns suggest he closely monitors company performance and market conditions, adapting accordingly. His most notable financial moves took place in 2023, where he engaged in meaningful trading activities, indicating a proactive stance in managing his stakes as the company evolves.